Tetherex Pharmaceuticals Corp is a clinical-stage development biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases. Its lead program is built around an antibody called SelK2 directed against the cell adhesion molecule P-Selectin Glycoprotein Ligand-1 (PSGL-1). SelK2 is currently under clinical development in a Phase 1 clinical study for Crohn's disease.
|HQ||Oklahoma City, US||Map|
Tetherex total Funding
Tetherex latest funding size
Time since last funding
|3 years ago|
When was Tetherex founded?
Tetherex was founded in 2014.
Who are Tetherex competitors?
Competitors of Tetherex include Shanghai Henlius Biotech, Cellectar Biosciences and Agenus.
Where is Tetherex headquarters?
Tetherex headquarters is located at 840 Research Pkwy #516, Oklahoma City.
Where are Tetherex offices?
Tetherex has offices in Oklahoma City and Morrisville.
How many offices does Tetherex have?
Tetherex has 2 offices.
Receive alerts for 300+ data fields across thousands of companies